Paul Tudor Jones’s West Pharmaceutical WST Stock Holding History

Paul Tudor Jones’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$431K	Buy	+1,200	New	+$367K	﹤0.01%	2928
2025 Q3	–	Sell	-1,600	Closed	-$350K	–	3972
2025 Q2	$350K	Buy	+1,600	New	+$342K	﹤0.01%	2801
2024 Q4	–	Sell	-4,300	Closed	-$1.29M	–	3574
2024 Q3	$1.29M	Buy	+4,300	New	+$1.32M	﹤0.01%	1468
2023 Q4	–	Sell	-700	Closed	-$263K	–	2963
2023 Q3	$263K	Sell	700 -300	-30%	-$116K	﹤0.01%	1983
2023 Q2	$382K	Buy	+1,000	New	+$357K	﹤0.01%	1863
2021 Q3	–	Sell	-1,600	Closed	-$575K	–	2849
2021 Q2	$575K	Buy	+1,600	New	+$529K	0.01%	1110

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Paul Tudor Jones's WST Position: Q2 2026 in Review

Paul Tudor Jones reduced its West Pharmaceutical (WST) stake by 64% in Q2 2026, selling an estimated $12.7M and leaving 23,851 shares worth $8.56M. The position accounts for 0.01% of the portfolio, ranked #916.

Paul Tudor Jones first reported a position in WST in Q2 2013 and has held it in 27 quarters since. The position peaked at $20.6M in Q3 2023. 827 funds tracked by Wall St. Rank hold WST as of Q2 2026.

Paul Tudor Jones held 23,851 shares of West Pharmaceutical worth $8.56M as of Q2 2026.
Paul Tudor Jones sold 41,564 West Pharmaceutical shares in Q2 2026, an estimated $12.7M.
West Pharmaceutical made up 0.01% of Paul Tudor Jones's portfolio in Q2 2026, its #916 holding.
Paul Tudor Jones first reported a position in West Pharmaceutical in Q2 2013 and has held it in 27 quarters since.
Paul Tudor Jones's West Pharmaceutical position peaked at $20.6M in Q3 2023.
827 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.